Dual-Modal Therapeutic Nanoplatform: Harnessing Caspase-1/GSDMD Pyroptosis and Photothermal Effects for Tumor Treatment
Authors:
- 29 December 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Abstract
Currently, most cancer treatment strategies focus on surgical resection of malignant tumors, complemented by physicochemical therapies such as radiotherapy and chemotherapy. However, these approaches are plagued by critical limitations, including suppression of normal cell growth and severe systemic toxicity-related side effects. In recent years, novel cancer therapeutic modalities, particularly photothermal therapy (PTT), have arisen potentially viable alternatives to tumor therapy, because of their minimal side effects, precise controllability, and superior selectivity. This research is designed to develop an integrated antitumor, NIR-II-responsive nanoparticle, and to investigate its therapeutic potential through efficacy assessment in both cellular and animal models, along with mechanistic studies. Specifically, we engineered a hybrid nanosystem by incorporating the NIR-II fluorescent dye IR817 into the zeolitic imidazolate framework ZIF-8. This design strategy significantly enhances the IR817 photothermal conversion efficiency and bolsters the overall photothermal therapeutic efficacy. Notably, the dual functionality of ZIF-8 as both a nanocarrier and a pyroptosis inducer, combined with the photothermal effect of IR817, thereby provides improved overall antitumor outcomes.Keywords
Funding Information
- Southwest Medical University (2024LCYXZX28)
- Southwest Medical University (2024ZXYZX09)
- Luzhou Science and Technology Bureau (2023JYJ011)
- Luzhou Science and Technology Bureau (2024JYJ003)
This publication has 42 references indexed in Scilit:
- Cellular and molecular aspects of drug resistance in cancersDARU Journal of Pharmaceutical Sciences, 2024
- Engineering of Nanofibers Embedded with Targeted Nanoparticles Breaks Redox Levers for Glioblastoma TherapyAdvanced Functional Materials, 2024
- A dual-pathway pyroptosis inducer based on Au–Cu2-xSe@ZIF-8 enhances tumor immunotherapy by disrupting the zinc ion homeostasisActa Biomaterialia, 2024
- Tunable Zeolitic Imidazolate Framework‐8 Nanoparticles for Biomedical ApplicationsSmall Methods, 2023
- ZIF‐8 Nanoparticles Evoke Pyroptosis for High‐Efficiency Cancer ImmunotherapyAngewandte Chemie International Edition, 2023
- Reactive Oxygen Species‐Mediated Pyroptosis with the Help of Nanotechnology: Prospects for Cancer TherapyAdvanced NanoBiomed Research, 2022
- ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer ImmunotherapyAdvanced Materials, 2021
- Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer TherapyAngewandte Chemie International Edition, 2020
- Zeolitic imidazolate framework-8 (ZIF-8) for drug delivery: A critical reviewFrontiers of Chemical Science and Engineering, 2020
- Two‐Dimensional Nanomaterials for Photothermal TherapyAngewandte Chemie International Edition, 2020